Passage Bio Earnings Estimate
| PASG Stock | USD 11.34 1.26 10.00% |
Passage Bio Earnings Estimation Breakdown
The calculation of Passage Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Passage Bio is estimated to be -2.792 with the future projection ranging from a low of -3.4775 to a high of -0.5875. Please be aware that this consensus of annual earnings estimates for Passage Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-3.48 Lowest | Expected EPS | -0.59 Highest |
Passage Bio Earnings Projection Consensus
Suppose the current estimates of Passage Bio's value are higher than the current market price of the Passage Bio stock. In this case, investors may conclude that Passage Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Passage Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 6 | 34.78% | -2.44 | -2.792 | -14.62 |
Passage Bio Earnings per Share Projection vs Actual
Actual Earning per Share of Passage Bio refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Passage Bio predict the company's earnings will be in the future. The higher the earnings per share of Passage Bio, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Passage Bio Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Passage Bio, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Passage Bio should always be considered in relation to other companies to make a more educated investment decision.Passage Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Passage Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-11-10 | 2025-09-30 | -0.2 | -2.44 | -2.24 | 1120 | ||
2025-08-12 | 2025-06-30 | -0.202 | -2.96 | -2.758 | 1365 | ||
2025-05-12 | 2025-03-31 | -0.2233 | -0.25 | -0.0267 | 11 | ||
2025-03-03 | 2024-12-31 | -0.2 | -0.2 | 0.0 | 0 | ||
2024-11-11 | 2024-09-30 | -0.23 | -0.2355 | -0.0055 | 2 | ||
2024-08-08 | 2024-06-30 | -0.31 | -0.26 | 0.05 | 16 | ||
2024-05-14 | 2024-03-31 | -0.36 | -0.3 | 0.06 | 16 | ||
2024-03-04 | 2023-12-31 | -0.4 | -0.3 | 0.1 | 25 | ||
2023-11-13 | 2023-09-30 | -0.46 | -0.49 | -0.03 | 6 | ||
2023-08-07 | 2023-06-30 | -0.48 | -0.44 | 0.04 | 8 | ||
2023-05-11 | 2023-03-31 | -0.5 | -0.63 | -0.13 | 26 | ||
2023-03-06 | 2022-12-31 | -0.52 | -0.49 | 0.03 | 5 | ||
2022-11-10 | 2022-09-30 | -0.79 | -0.49 | 0.3 | 37 | ||
2022-08-04 | 2022-06-30 | -0.83 | -0.73 | 0.1 | 12 | ||
2022-05-16 | 2022-03-31 | -0.89 | -0.79 | 0.1 | 11 | ||
2022-03-03 | 2021-12-31 | -0.89 | -0.95 | -0.06 | 6 | ||
2021-11-04 | 2021-09-30 | -0.86 | -0.87 | -0.01 | 1 | ||
2021-08-05 | 2021-06-30 | -0.76 | -0.9 | -0.14 | 18 | ||
2021-05-05 | 2021-03-31 | -0.74 | -0.76 | -0.02 | 2 | ||
2021-03-03 | 2020-12-31 | -0.7 | -0.85 | -0.15 | 21 | ||
2020-11-10 | 2020-09-30 | -0.76 | -0.63 | 0.13 | 17 | ||
2020-08-13 | 2020-06-30 | -0.57 | -0.6 | -0.03 | 5 | ||
2020-05-11 | 2020-03-31 | -0.45 | -1.0 | -0.55 | 122 | ||
2020-02-28 | 2019-12-31 | -0.69 | -0.69 | 0.0 | 0 |
About Passage Bio Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Passage Bio earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Passage Bio estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Passage Bio fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -593.3 M | -563.6 M | |
| Retained Earnings Total Equity | -443.2 M | -465.3 M | |
| Earnings Yield | (2.17) | (2.07) | |
| Price Earnings Ratio | (0.48) | (0.50) | |
| Price Earnings To Growth Ratio | 0.01 | 0.01 |
Currently Active Assets on Macroaxis
When determining whether Passage Bio is a strong investment it is important to analyze Passage Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Passage Bio's future performance. For an informed investment choice regarding Passage Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Passage Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Can Biotechnology industry sustain growth momentum? Does Passage have expansion opportunities? Factors like these will boost the valuation of Passage Bio. Anticipated expansion of Passage directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Passage Bio demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Investors evaluate Passage Bio using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Passage Bio's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Passage Bio's market price to deviate significantly from intrinsic value.
It's important to distinguish between Passage Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Passage Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Passage Bio's market price signifies the transaction level at which participants voluntarily complete trades.